Serum Expression of IL-33 and ST2 in Patients with Psoriasis Vulgaris

Yonghua Dong ¹ , Hua Hu ¹, Dandan Fu ¹, Shuting Zheng ¹, Qingqing Wang ¹, Keshav K C ¹, Xiangfeng Song ², Zhongwei Tian ¹ *

Cited by CrossRef: 3

1- Fu D, Zheng S, Li J, Hu H, Wang Q, Fu X, Li M, Yan D, Yang Z, Tian Z, Song X. Anti-interleukin 33 treatment alleviates psoriatic dermatitis in mice induced imiquimod. International Immunopharmacology. 2023;121:110480 [Crossref]

2- Zhao P, Zhang J, Liu B, Tang Y, Wang L, Wang G, Wu H, Yang C, Li X, Li B. Causal Effects of Circulating Cytokines on the Risk of Psoriasis Vulgaris: A Mendelian Randomization Study. Front Genet. 2022;13 [Crossref]

3- Zhou G, Ren X, Tang Z, Li W, Chen W, He Y, Wei B, Zhang H, Ma F, Chen X, Zhang G, Shen M, Liu H. Exploring the association and causal effect between white blood cells and psoriasis using large-scale population data. Front Immunol. 2023;14 [Crossref]

4- Alsabbagh M. Cytokines in psoriasis: From pathogenesis to targeted therapy. Human Immunology. 2024;85(4):110814 [Crossref]

5- Ertel A, Anderegg U, Franz S, Saalbach A. Dermal White Adipose Tissue–Derived Il-33 Regulates Il-4/13 Expression in Myeloid Cells during Inflammation. Journal of Investigative Dermatology. 2024; [Crossref]

Submit Your Paper Notification Instructions for Authors Aims and Scope Editorial policies Editorial Board AIM old site Archive

About Us

A Monthly Peer-Reviewed Medical Journal Published by the Academy of Medical Sciences of the I.R. Iran; Indexed in PubMed/MEDLINE, ISI Web of Science, EMBASE, SCOPUS, CINHAL, PASCAL, CSA, SID, ISSN: Print 1029-2977, Online 1735-3947.The impact factor of Archives of Iranian Medicine according to Journal Citation Reports® (JCR®) 2016 is 1.20.